Answers are grounded in this paper and cite their sources.
Randomized trial evaluates the impact of a high-phytosterol diet on immune markers in Chinese adults with dyslipidemia, suggesting potential immune benefits.
Dyslipidemia is associated with chronic low-grade inflammation and immune dysfunction, but the immunological effects of dietary phytosterols in humans remain unclear. We conducted a secondary analysis of an outcome-assessor-blinded, randomized controlled feeding trial to evaluate the effects of a high-phytosterol (HPS) diet, using phytosterol-enriched corn–wheat germ blended oil, compared with a low-phytosterol (LPS) diet using peanut oil, on systemic inflammatory markers, humoral immune markers and peripheral blood lymphocyte subsets in Chinese adults with dyslipidemia. After a 2-week run-in period, 104 participants were randomized to the HPS group (n=52) or the LPS group (n=52) for 12 weeks. In intention-to-treat analyses, the HPS group had a higher CD4 + /CD8 + ratio at 12 weeks than the LPS group (adjusted mean difference: 0.561; 95 % CI: 0.060, 1.063; P = 0.03) and a lower CD8 + T-cell count (adjusted mean difference: -116.315 cells/μL; 95 % CI: -215.781,-16.849; P = 0.02). No significant between-group differences were observed for systemic inflammatory markers, humoral immune markers or most other lymphocyte subset outcomes. In per-protocol analyses, the difference in CD4 + /CD8 + ratio remained significant, whereas the reduction in CD8 + T-cell count was attenuated. These exploratory findings suggest that a 12-week phytosterol-enriched corn–wheat germ blended oil intervention may be associated with changes in T-cell subset balance in adults with dyslipidemia, although the results should be interpreted cautiously given the exploratory nature of this secondary analysis.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: